Merck says to seek 3 drug approvals in 2007
408786
Merck & Co. on Tuesday said it aims to seek U.S. approvals next year for drugs to treat HIV, cholesterol and insomnia and aims to have another four products in late-stage trials by mid-2007.
682721
Biotech companies, medical device  makers and food manufacturers joined patient groups and three  former U.S. health secretaries on Monday in calling for  increased funding for the Food and Drug Administration.
377994
Drugmaker Merck & Co. Inc.  boosted its 2007 earnings forecast on Wednesday, citing better-than-expected sales of multiple products, including its cancer vaccine Gardasil and diabetes drug Januvia.
120706
Merck & Co  on Monday said its third-quarter profit rose sharply, helped by sales of its vaccines and cholesterol drugs, and raised its 2007 profit forecast in view of strong current trends.
311786
Abbott Laboratories Inc. said Tuesday it is seeking regulatory approval for a drug to treat advanced prostate cancer that has spread through the body.
240261
Amid questions about whether the arthritis drug Vioxx was taken off the market soon enough, a key senator suggested Friday that an independent board of drug safety might be needed to ensure the safety of medications after they're approved for the market.
361813
The Wall Street Journal has reported that pharmaceutical company Merck knew as far back as 2000 that its arthritis medication, Vioxx, was linked to an increased risk of heart attack.
226304
The announcement comes on the eve of a three-day FDA meeting called to discuss the safety of painkillers like Merck &#38; Co.
22206
Internal e-mails and other documents from Merck &amp; Co. show the company fought for years to keep safety concerns from undermining the drug&#39;s commercial prospects, the Wall Street Journal reported on Monday.
494116
A leading U.S. Senate Republican  this week demanded internal documents from Merck & Co. Inc.  MRK.N that could answer questions about the company's  interaction with U.S. regulators over its arthritis drug Vioxx.
524607
By Christopher Bowe and Andrew Jack in Whitehouse Station, New Jersey. Merck has quickened the pace of its restructuring with plans to cut a further 700 jobs, targeting about $3bn in savings by the end of 2008
197674
Medicare beneficiaries will have more options for prescription drug coverage in 2007, officials said.
392641
Drugmaker Merck & Co. Inc.  boosted its 2007 earnings forecast on Wednesday, based on early revenue indications from a range of products, sending its shares up nearly 3 percent in early electronic trading.
92266
Wyeth is seeking US approval in the next 18 months of seven new drugs that may ultimately generate more than $6 billion in annual revenue, chief executive Robert Essner told analysts.
399387
Merck &amp; Co. Inc. agreed Wednesday to pay $2.3 billion to resolve several tax disputes, the Internal Revenue Service said.
528763
Progenics and partner Wyeth announce plans to start three new clinical trials.
20994
Pfizer plans to ask or approval of torcetrapib, a heart drug crucial to the companyÂs future, despite evidence that the drug increases blood pressure.